Loading
A phase 2 trial in colorectal cancer, run by Ann-Sofie Backman, now recruiting.
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome is a phase 2, randomised interventional study registered as NCT04920149 by Ann-Sofie Backman, with a registry enrolment figure of 150 participants, started 2022-03-21 and due to reach its primary completion in 2032-09-30. Interventions recorded: Mesalamine; Placebo. Conditions listed: Lynch Syndrome; Colon Cancer; Colon Neoplasm. Primary outcome: Change in the occurrence of any colorectal neoplasia in LS patients; Change in the occurrence of any colorectal neoplasia in LS patients. Colorectal eligibility wording from the registry: "* Presence of colorectal endoscopically non-removable benign neoplasia (patient can be included if the adenoma is removed)". Sites: Denmark, Sweden. No results are recorded here; the registry entry is the source.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.